{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:55:11Z","timestamp":1790945711239,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.clim.2017.07.008","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T02:31:45Z","timestamp":1500258705000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["X-Linked Agammaglobulinaemia: Outcomes in the modern era"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4407-5998","authenticated-orcid":false,"given":"Ben","family":"Shillitoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.07.008_bb0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.07.008_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2249.2009.03954.x","article-title":"The European internet-based patient and research database for primary immunodeficiencies: results 2006\u20132008","volume":"157","author":"Gathmann","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.12172","article-title":"The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008\u20132012","volume":"175","author":"Edgar","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.clim.2017.07.008_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/CRIAI:19:2:183","article-title":"X-linked agammaglobulinemia","volume":"19","author":"Conley","year":"2000","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clim.2017.07.008_bb0030","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"BRUTON","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.clim.2017.07.008_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.69.1.119","article-title":"An electrophoretic study of immune sera and purified antibody preperations","volume":"69","author":"Tiselius","year":"1939","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1039\/tf9373300524","article-title":"A new apparatus for electrophoretic analysis of colloidal mixtures","volume":"33","author":"Tiselius","year":"1937","journal-title":"Trans. Faraday Soc."},{"key":"10.1016\/j.clim.2017.07.008_bb0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1521-6616(03)00045-7","article-title":"Stem cell transplants for patients with X-linked agammaglobulinemia","volume":"107","author":"Howard","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0055","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1172\/JCI76175","article-title":"Splice-correcting oligonucleotides restore Btk function in X-linked agammaglobulinemia model","volume":"124","author":"Bestas","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.07.008_bb0060","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2009-09-241869","article-title":"B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia","volume":"115","author":"Kerns","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.07.008_bb0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12185-015-1732-1","article-title":"Mutations in Bruton's tyrosine kinase impair IgA responses","author":"Mitsuiki","year":"2015","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.clim.2017.07.008_bb0070","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199405263302104","article-title":"A point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia","volume":"330","author":"Saffran","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF03401645","article-title":"A novel mutation (Cys145--&gt;Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male","volume":"2","author":"Kornfeld","year":"1996","journal-title":"Mol. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2017.07.008_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2017.07.008_bb0095","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q. J. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0100","first-page":"1","article-title":"Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia","volume":"76","author":"Garbett","year":"1989","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jaci.2011.09.047","article-title":"Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia","volume":"129","author":"Micol","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/bj2710285","article-title":"The structure and function of human IgA","volume":"271","author":"Kerr","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2017.07.008_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10875-015-0230-9","article-title":"Risk of infections among 2100 individuals with IgA deficiency: a nationwide cohort study","author":"Ludvigsson","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2005.11.002","article-title":"The health status and quality of life of adults with X-linked agammaglobulinemia","volume":"118","author":"Howard","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2249.1997.4831379.x","article-title":"Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies","volume":"109","author":"Buehring","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/adc.88.12.1101","article-title":"Pulmonary and sinus diseases in primary humoral immunodeficiencies with chronic productive cough","volume":"88","author":"Rusconi","year":"2003","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.clim.2017.07.008_bb0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10875-017-0374-x","article-title":"Gastrointestinal manifestations in X-linked agammaglobulinemia","volume":"37","author":"Barmettler","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.aller.2013.09.013","article-title":"Mortality and morbidity in patients with X-linked agammaglobulinaemia","volume":"43","author":"Abolhassani","year":"2015","journal-title":"Allergol. Immunopathol. (Madr.)"},{"key":"10.1016\/j.clim.2017.07.008_bb0145","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00431-008-0674-5","article-title":"Novel Btk mutation presenting with vaccine-associated paralytic poliomyelitis","volume":"167","author":"Mamishi","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.clim.2017.07.008_bb0150","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM197706302962601","article-title":"Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia","volume":"296","author":"Wilfert","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0155","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/clinids\/9.2.334","article-title":"Chronic enteroviral meningoencephalitis in agammaglobulinemic patients","volume":"9","author":"McKinney","year":"1987","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.clim.2017.07.008_bb0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2016.06.014","article-title":"Treatment of chronic enterovirus encephalitis with fluoxetine in a patient with X-linked agammaglobulinemia","volume":"64","author":"Gofshteyn","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.clim.2017.07.008_bb0165","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s10875-016-0284-3","article-title":"Respiratory health and related quality of life in patients with congenital agammaglobulinemia in the northern region of the UK","volume":"36","author":"Bryan","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-013-9942-x","article-title":"Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes","volume":"34","author":"Hurst","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0091-6749(91)90306-9","article-title":"Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia","volume":"88","author":"Sweinberg","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0180","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.07.008_bb0185","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/S0041-1345(03)00713-9","article-title":"Lung transplantation in patients with x-linked agammaglobulinemia","volume":"35","author":"Morales","year":"2003","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.clim.2017.07.008_bb0190","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CFbronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.clim.2017.07.008_bb0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1081\/COPD-200050685","article-title":"Outcome in adult bronchiectasis","volume":"2","author":"King","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.clim.2017.07.008_bb0200","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.clim.2017.07.008_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-13-21","article-title":"Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients","volume":"13","author":"Goeminne","year":"2012","journal-title":"Respir. Res."},{"key":"10.1016\/j.clim.2017.07.008_bb0210","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2017.07.008_bb0215","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(15)00202-7","article-title":"Review lung disease in primary antibody deficiency","volume":"3","author":"Verma","year":"2015","journal-title":"Lancet Respir."},{"key":"10.1016\/j.clim.2017.07.008_bb0220","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1440-1843.2011.02067.x","article-title":"Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease","volume":"17","author":"Montella","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.clim.2017.07.008_bb0225","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10875-015-0172-2","article-title":"Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies","volume":"35","author":"Milito","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0230","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1378\/chest.10-3147","article-title":"Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity","volume":"140","author":"Serra","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.clim.2017.07.008_bb0235","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2011.03.041","article-title":"Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies","volume":"127","author":"Chen","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0240","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2249.2007.03550.x","article-title":"Serial lung function tests in primary immune deficiency","volume":"151","author":"Rich","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0245","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.08-0776","article-title":"Bronchiectasis","volume":"134","author":"O'Donnell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.clim.2017.07.008_bb0250","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.rmed.2007.06.007","article-title":"Role of physiotherapy in the management of chronic lung diseases: an overview of systematic reviews","volume":"101","author":"Garrod","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0255","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2008.110726","article-title":"Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient","volume":"64","author":"Bott","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.clim.2017.07.008_bb0260","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1007\/BF00918361","article-title":"Individual patient variations in the kinetics of intravenous immune globulin administration","volume":"2","author":"Pirofsky","year":"1982","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0265","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2014.00629","article-title":"Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in Europe","volume":"5","author":"Kerr","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0149-2918(96)80200-1","article-title":"Intravenous immunoglobulin and hepatitis C virus: the British episode","volume":"18","author":"Healey","year":"2016","journal-title":"Clin. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2017.07.008_bb0275","first-page":"S47","article-title":"Virus validation studies of immunoglobulin preparations","volume":"14","author":"Biesert","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2017.07.008_bb0280","series-title":"UKPIN 2015 Meet., Belfast","article-title":"The use of intravenous pentaglobin in a subset of patients with severe mucosal complications related to primary immune deficiency","author":"Ghurye","year":"2015"},{"key":"10.1016\/j.clim.2017.07.008_bb0285","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaci.2012.04.032","article-title":"Immunoglobulin replacement therapy: is there a role for IgA and IgM?","volume":"130","author":"Kiani-Alikhan","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0290","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijantimicag.2010.11.027","article-title":"Immunoglobulin treatment in primary antibody deficiency","volume":"37","author":"Maarschalk-Ellerbroek","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.clim.2017.07.008_bb0295","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1183\/09031936.01.00228801","article-title":"Lung mucosal immunity: immunoglobulin-a revisited","volume":"18","author":"Pilette","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2017.07.008_bb0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cei.12521","article-title":"Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?","volume":"178","author":"Baumann","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0305","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0310","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0315","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10875-017-0381-y","article-title":"Low IgA and IgM is associated with a higher prevalence of bronchiectasis in primary antibody deficiency","volume":"37","author":"Hodkinson","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0320","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2017.07.008_bb0325","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.intimp.2004.02.011","article-title":"Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency","volume":"4","author":"de Gracia","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2017.07.008_bb0330","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial","volume":"135","author":"Eijkhout","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0335","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0345","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2008.03851.x","article-title":"Clinical immunology review series: an approach to the management of pulmonary disease in primary antibody deficiency","volume":"155","author":"Tarzi","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0350","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2015.07.001","article-title":"The ratio of mean daily IgG increment\/mean daily dose in immunoglobulin replacement therapy in primary antibody deficiencies","volume":"3","author":"Lucas","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2017.07.008_bb0355","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/cei.12002","article-title":"Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor","volume":"171","author":"Gouilleux-Gruart","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/cei.12529","article-title":"Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patients","volume":"178","author":"Litzman","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/eji.1830130214","article-title":"Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice II. Anti-\u03bc treatment affects the initiation and recruitment of T cells","volume":"13","author":"Ron","year":"1983","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0370","first-page":"1570","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Am. Soc. Hematol."},{"key":"10.1016\/j.clim.2017.07.008_bb0375","doi-asserted-by":"crossref","unstructured":"G. Meyers, Y. Ng, J.M. Bannock, A. Lavoie, J.E. Walter, L.D. Notarangelo, Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans, 108 (2011). doi:http:\/\/dx.doi.org\/10.1073\/pnas.1102600108.","DOI":"10.1073\/pnas.1102600108"},{"key":"10.1016\/j.clim.2017.07.008_bb0380","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1189\/jlb.0513307","article-title":"Bruton's tyrosine kinase\u2014an integral protein of B cell development that also has an essential role in the innate immune system","volume":"95","author":"L\u00f3pez-Herrera","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2017.07.008_bb0385","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni.2234","article-title":"The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils","volume":"13","author":"Honda","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0390","doi-asserted-by":"crossref","first-page":"23769","DOI":"10.1074\/jbc.M112.372425","article-title":"Tyrosine kinase Btk is required for NK cell activation","volume":"287","author":"Bao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.07.008_bb0395","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaci.2013.12.1085","article-title":"Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation","volume":"133","author":"Lougaris","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0400","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood.V99.8.2694","article-title":"Autoimmunity in human primary immunodeficiency diseases","volume":"99","author":"Arkwright","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.07.008_bb0405","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10875-014-0056-x","article-title":"Autoimmunity and inflammation in X-linked agammaglobulinemia","volume":"34","author":"Hernandez-Trujillo","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0410","first-page":"3","article-title":"Nutritional status in agammaglobulinemia: an Italian multicenter study","author":"Dellepiane","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0415","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/1097-0142(19930901)72:5<1528::AID-CNCR2820720506>3.0.CO;2-V","article-title":"X-linked agammaglobulinemia and gastric adenocarcinoma","volume":"72","author":"Lavilla","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.clim.2017.07.008_bb0420","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0140-6736(93)90883-I","article-title":"Colorectal cancer in patients with X-linked agammaglobulinaemia","volume":"341","author":"van der Meer","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2017.07.008_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(95)70491-4","article-title":"Cancer in children with primary or secondary immunodeficiencies","volume":"126","author":"Mueller","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2017.07.008_bb0430","first-page":"10","article-title":"Gastric adenocarcinoma in the context of X-linked agammaglobulinemia : case report and review of the literature","author":"Staines Boone","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0435","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-016-0241-1","article-title":"Life with a primary immune deficiency: a systematic synthesis of the literature and proposed research agenda","author":"Similuk","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0440","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10875-014-0072-x","article-title":"Quality of life in children with primary antibody deficiency","volume":"34","author":"Titman","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0445","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10875-008-9270-8","article-title":"The quality of life of children and adolescents with X-linked agammaglobulinemia","volume":"29","author":"Soresina","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0450","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1359104509338432","article-title":"Parental and child perspectives on adaptation to childhood chronic illness: a qualitative study","volume":"15","author":"Gannoni","year":"2010","journal-title":"Clin. Child Psychol. Psychiatry"},{"key":"10.1016\/j.clim.2017.07.008_bb0455","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jpepsy\/17.2.133","article-title":"Psychological adjustment to pediatric physical disorders: a meta-analytic review","volume":"17","author":"Lavigne","year":"1992","journal-title":"J. Pediatr. Psychol."},{"key":"10.1016\/j.clim.2017.07.008_bb0460","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.79.5.805","article-title":"Chronic illness, disability, and mental and social well-being: findings of the Ontario Child Health Study","volume":"79","author":"Cadman","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.clim.2017.07.008_bb0465","first-page":"1","article-title":"Status of adults with X-linked agammaglobulinemia","volume":"9","author":"Winkelstein","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2017.07.008_bb0470","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2013.2087","article-title":"After 50 years, newborn screening continues to yield public health gains","volume":"309","author":"Kuehn","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2017.07.008_bb0475","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10875-014-0029-0","article-title":"The case for mandatory newborn screening for severe combined immunodeficiency (SCID)","volume":"34","author":"Gaspar","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0480","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-08-371021","article-title":"Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR","volume":"119","author":"Borte","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.07.008_bb0485","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/316260a0","article-title":"A uniform deleting element mediates the loss of kappa genes in human B cells","volume":"316","author":"Siminovitch","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.07.008_bb0490","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2011.01.052","article-title":"Quantification of k-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects","volume":"128","author":"Nakagawa","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0495","first-page":"1","article-title":"Newborn screening for severe primary immunodeficiency diseases in Sweden-a 2-year pilot TREC and KREC screening study","author":"Barbaro","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0500","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/pai.12501","article-title":"Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville","volume":"27","author":"de Felipe","year":"2015","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.clim.2017.07.008_bb0505","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2017.07.008_bb0510","first-page":"404","article-title":"Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study","volume":"15","author":"Somech","year":"2013","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.clim.2017.07.008_bb0515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jfma.2012.10.020","article-title":"Incidence of severe combined immunodeficiency through newborn screening in a Chinese population","volume":"114","author":"Chien","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.clim.2017.07.008_bb0520","series-title":"The Principles and Practice of Mass Screening for Disease","author":"Wilson","year":"1968"},{"key":"10.1016\/j.clim.2017.07.008_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.25554","article-title":"Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia","author":"Abu-Arja","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.clim.2017.07.008_bb0530","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13045-016-0240-y","article-title":"Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity","volume":"9","author":"Ikegame","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.clim.2017.07.008_bb0535","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-01-688226","article-title":"Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency","author":"Cicalese","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.07.008_bb0540","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/gt.2008.17","article-title":"Development of an enhanced B-specific lentiviral vector expressing Btk: a tool for gene therapy of XLA","volume":"15","author":"Moreau","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.clim.2017.07.008_bb0545","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1089\/hum.2012.116","article-title":"Gene therapy for primary immunodeficiencies","volume":"23","author":"Rivat","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.clim.2017.07.008_bb0550","doi-asserted-by":"crossref","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-bey-abina","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.07.008_bb0555","first-page":"3143","article-title":"Insertional mutagenesis in combination with acquired somatic mutations leads to leukemogenesis following gene therapy of SCID-X1","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.clim.2017.07.008_bb0560","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2017.07.008_bb0565","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.celrep.2015.08.013","article-title":"Modeling human severe combined immunodeficiency and correction by CRISPR\/Cas9-enhanced gene targeting","volume":"12","author":"Chang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2017.07.008_bb0570","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1182\/blood-2003-09-3044","article-title":"Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer","volume":"104","author":"Yu","year":"2004","journal-title":"Blood"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617302292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617302292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:00:00Z","timestamp":1761494400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617302292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":114,"alternative-id":["S1521661617302292"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.07.008","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"X-Linked Agammaglobulinaemia: Outcomes in the modern era","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}